ATC Group: C05BA04 Pentosan polysulfate sodium

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C05BA04 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C05 Vasoprotectives
3 C05B Antivaricose therapy
4 C05BA Heparins or heparinoids for topical use
5 C05BA04 Pentosan polysulfate sodium

Active ingredients in C05BA04

Active Ingredient Description
Pentosan polysulfate

The hypothetic mechanism of action of pentosan polysulfate includes a local effect in the bladder after systemic administration and excretion into the urine by binding of glycosaminoglycans to the deficient mucous of the bladder. It is hypothesized, that a potential barrier function of pentosan polysulfate instead of the damaged urothelial mucus might play a role as well the antiinflammatory activity of pentosan polysulfate sodium.

Medicines in this ATC group

Austria (AT)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.